Synucure Therapeutics’ Scientific Advisory Board brings together international experts in neurology, neurogenetics, neuropsychiatry, and movement disorders.
Established to support the company in developing innovative treatments for Parkinson’s disease, the board provides independent expertise on Synucure’s scientific and clinical directions.
Dr. Camila Aquino
PhD

Pr. Dominique Bonneau
MD, PhD
- Medical geneticist, Professor of Medical Genetics, Head of the Clinical Genetics Unit at Angers University Hospital and affiliated researcher at INSERM.
- Member of the French National Reference Center for Neurogenetic Diseases, with a clinical research focus on neurogenetic disorders, including Huntington’s disease.
- Author and co-author of over 350 publications, with major contributions to the identification of genes involved in rare neurological and developmental disorders.
- Principal Investigator of a clinical trial evaluating cysteamine in Huntington’s disease.

Pr. Roger A. Barker
MD, PhD, FMedSci
- Professor in the Department of Clinical Neurosciences at the University of Cambridge and Honorary Consultant Neurologist at Addenbrooke’s Hospital in Cambridge.
- Lead academic scientist at the Alborada Drug Discovery Institute and the John van Geest Centre for Brain Repair.
- Clinical lead for the regional Huntington’s Disease Clinic.
- Chair of Neurodegeneration at LifeArc and Co-Editor in Chief of the Journal of Neurology.

Dr. Ray Dorsey
MD, MBA
- Director of the Center for the Brain & the Environment at the Atria Health and Research Institute.
- Co-author of Ending Parkinson’s Disease and the forthcoming The Parkinson’s Plan.
- Previously led the movement disorders division at Johns Hopkins, directed the Center for Health + Technology at the University of Rochester, chaired the international Huntington Study Group, and consulted for McKinsey & Company.
- Named a “Champion for Change” for Parkinson’s disease by the White House in 2015.

Dr Christopher A. Ross
MD, PhD
- Professor in the Department of Clinical Neurosciences at the University of Cambridge and Honorary Consultant Neurologist at Addenbrooke’s Hospital in Cambridge.
- Lead academic scientist at the Alborada Drug Discovery Institute and the John van Geest Centre for Brain Repair.
- Clinical lead for the regional Huntington’s Disease Clinic.
- Chair of Neurodegeneration at LifeArc and Co-Editor in Chief of the Journal of Neurology.